SGLT-2 inhibitors and GLP-1 receptor agonists for Type 2 diabetes
Acad Emerg Med. 2024 Mar 17. doi: 10.1111/acem.14895. Online ahead of print.NO ABSTRACTPMID:38494877 | DOI:10.1111/acem.14895
Source: Accident and Emergency Nursing - Category: Emergency Medicine Authors: Esteban Davila James McCormack Source Type: research
More News: Accidents | Diabetes | Diabetes Type 2 | Emergency Medicine | Endocrinology | Nurses | Nursing